
Anne Douar, Chief Development Officer of Vivet Therapeutics, will give a presentation

VIVET ATTENDING CHARDAN'S 4th ANNUAL GENETIC MEDICINES CONFERENCE

VIVET ATTENDING THE HEALTHTECH INNOVATION DAYS (HTID) IN PARIS

Bernard Benichou Vivet Therapeutics' CMO will be participating to a panel and Jean-Philippe Combal, CEO and Sonia Valero, Head of Clinical Operations…

Vivet Therapeutics, a privately held gene therapy biotech company

Vivet Therapeutics' CEO, Jean-Philippe Combal

Jean-Philippe Combal, Vivet Therapeutics' CEO, and Thomas Daniel, BD Director, will be hosting 1x1 meetings during

Vivet Therapeutics CEO, Jean-Philippe Combal

Dr. Gloria González-Aseguinolaza, Vivet Therapeutics CSO